Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital

Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital

CAR-T cell therapy is a promising treatment for acute leukemia and lymphoma. CAR-T cell therapies take a pioneering role in autologous gene therapy with three EMA-approved products. However, the chance of clinical success remains relatively low as the applicability of CAR-T cell therapy suffers from...

Full description

Bibliographic Details
Main Authors: Simon Hort, Laura Herbst, Niklas Bäckel, Frederik Erkens, Bastian Niessing, Maik Frye, Niels König, Ioannis Papantoniou, Michael Hudecek, John J. L. Jacobs, Robert H. Schmitt
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
ATMP
CAR-T cell
artificial intelligence
automation
autologous
manufacturing
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.913287/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.913287/full

Similar Items